The shares of Abbott Laboratories (NYSE:ABT) traded with a loss of -0.02 points or -0.04% in the most recent session. The shares last traded at $37.49. As per the trading info, the shares saw $52.36 million in upticks and lost $18.8 million in downticks, resulting in a net money flow of $33.55 million. The up/down ratio for the day was measured at 2.78. For the week, the shares had posted -2.38%.From the block trade data available, the total upticks were valued at $32.54 million and the total downticks were valued at $0.38 million, thereby putting the up/down ratio at 86.77. The net money flow for the block transaction was $32.16 million.
Abbott Laboratories has lost 2.63% in the last five trading days and dropped 0.95% in the last 4 weeks. Abbott Laboratories has dropped 7.78% during the last 3-month period . Year-to-Date the stock performance stands at -15.71%.
Currently the company Insiders own 0.26% of Abbott Laboratories shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -0.63% . Institutional Investors own 70.01% of Abbott Laboratories shares. During last six month period, the net percent change held by insiders has seen a change of -1.31%. . On the companys insider trading activities, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (Senior Vice President) of Abbott Laboratories, Watkin Jared had sold 552 shares worth of $20,772 in a transaction dated June 15, 2016. In this transaction, 552 shares were sold at $37.63 per share.
Abbott Laboratories (NYSE:ABT) witnessed a decline in the market cap on Friday as its shares dropped 0.29% or 0.11 points. After the session commenced at $37.4, the stock reached the higher end at $37.585 while it hit a low of $37.23. With the volume soaring to 9,899,994 shares, the last trade was called at $37.39. The company has a 52-week high of $51.74. The company has a market cap of $54,932 million and there are 1,469,152,000 shares in outstanding. The 52-week low of the share price is $36.
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a range of health care products. Abbott operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products.